Data as of Oct 24
| +0.28 / +19.58%|
The 5 analysts offering 12-month price forecasts for Sunesis Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 3.00 and a low estimate of 1.30. The median estimate represents a +16.96% increase from the last price of 1.71.
The current consensus among 7 polled investment analysts is to Hold stock in Sunesis Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.